Clinical Trial Update: GS-6615 in Adults With Chronic Stable Angina and Coronary Artery Disease [Phase 2]

View source ↗

Summary

A Phase 2 trial of GS-6615 for chronic stable angina and coronary artery disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Ischemic Heart Disease
• Stable Angina

Drugs mentioned

• GS-6615

Snippet

Sponsor: Gilead Sciences | Conditions: Ischemic Heart Disease | Phase 2 | Status: WITHDRAWN